Clinical Epidemiology
II. The Identification Rates of Disease
- ALVAN R. FEINSTEIN, M.D., F.A.C.P.
- Requests for reprints should be addressed to Alvan R. Feinstein, M.D., Yale University School of Medicine, 333 Cedar St., New Haven, Conn. 06510.
Excerpt
OUTLINE OF CONTENTS: PART II INTRODUCTION
FACTORS INFLUENCING IDENTIFICATION OF DISEASE
CHANGES IN NOMENCLATURE AND TECHNOLOGY
DISSEMINATION OF NEW STANDARDS
CHANGES IN IATROTROPY
CHANGES IN CODIFICATION
THE EPIDEMIOLOGIC SPECTRUM OF A DISEASE
IATROTROPIC AND DIAGNOSTIC PATHWAYS
CONSTRUCTION OF THE EPIDEMIOLOGIC SPECTRUM
CHANGES IN DIAGNOSTIC PROCEDURES
FASHIONS OF NOMENCLATURE
ECLECTIC DIAGNOSTIC CRITERIA
NEW TECHNOLOGIC TESTS
SUMMARY
INTRODUCTION When vital statistics was established more than a century ago as a numerical domain in what might now be called Clinical Epidemiology, the main problem was to arrange for collection of data (1, 2). Clinicians had to become accustomed to documenting births and deaths
Article and Author Information
-
From the Eastern Research Support Center and the Department of Medicine, West Haven Veterans Administration Hospital, West Haven; and the Departments of Medicine and Epidemiology, Yale University School of Medicine, New Haven; Conn
-
This study was supported in part by grant 13977-03-68-806, U. S. Public Health Service Cancer Control Program, Department of Health, Education and Welfare, Washington, D. C.
-
- Received April 8, 1968.
- Accepted May 31, 1968.
RSS Feeds









